Drug research

Zodasiran

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as ARO-ANG3

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaNCT07473843	Arrowhead Pharmaceuticals	Phase 3	Not yet recruiting	2028-07Estimated

Arrowhead PharmaceuticalsNot yet recruitingPrimary completion: 2028-07 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.